Advertisement
Ambipar Emergency Response

AMBI News Today: Stay Updated with the Latest Ambipar Emergency Response News in Real Time

Find AMBI news now at Meyka AI. Stay informed with the latest Ambipar Emergency Response stocks updates, including price news, market analysis, and expert insights.

AMBIAMEX
IndustrialsWaste Management
$0.44
$0.06(12.00%)
U.S. Market is Open · 12:27
Advertisement
Belfast Knife Attack Sparks Anti-Immigrant Riots, June 10
📅 in about 5 hours

Belfast Knife Attack Sparks Anti-Immigrant Riots, June 10

Sudanese man charged with attempted murder after knife attack in Belfast. Police deploy 200 extra officers as riots erupt.

Read more 12
EV Charging Market Grows to $15.2B by 2034 as Infrastructure Expands
📅 in about 3 hours

EV Charging Market Grows to $15.2B by 2034 as Infrastructure Expands

Grid-integrated EV charging market projected to reach $15.2B by 2034 at 10.1% CAGR, with ultra-fast infrastructure growing 16.3% annually.

Read more 12
Is Google Gemini Down? Users Report 1099 and 1076 Errors Worldwide
📅 in about 2 hours

Is Google Gemini Down? Users Report 1099 and 1076 Errors Worldwide

Thousands of users are asking whether Gemini Down is a real issue after widespread reports of error codes 1099 and 1076 appeared across multiple regions. Users from the United States, United Kingdom, Europe, Asia, and other markets reported being unable to generate responses through Google’s AI assistant. Reports increased sharply within a short period, suggesting…

Read more 12
France-Cyprus Defense Pact Sparks Turkey Warning, June 10
📅 in about 2 hours

France-Cyprus Defense Pact Sparks Turkey Warning, June 10

France and Cyprus sign defense agreement enabling French military deployment and cooperation in the Eastern Mediterranean region.

Read more 12
European Stocks Edge Higher as Investors Weigh US-Iran Tensions; WH Smith Plunges 16%
📅 1 hour ago

European Stocks Edge Higher as Investors Weigh US-Iran Tensions; WH Smith Plunges 16%

European stocks are holding their footing but only just. On June 10, 2026, the STOXX 600 opened at 621.72 and traded in a range of 621.10 to 625.22, as European shares edged up while investors parsed the fallout from US-Iran tensions with limited conviction across sectors. The FTSE 100 stood at 10,345, and the DAX…

Read more 12
Bitcoin Holds Near $61,244 as CPI Data, Iran Tensions, and ETF Outflows Fuel Market Uncertainty
📅 1 hour ago

Bitcoin Holds Near $61,244 as CPI Data, Iran Tensions, and ETF Outflows Fuel Market Uncertainty

Bitcoin is caught in a three-way squeeze. On June 9, 2026, Bitcoin traded at $62,747, down from its $82,000 May peak as rate-cut expectations flipped to rate-hike expectations following strong US jobs data. The US CPI report, scheduled for June 10, followed by the Federal Reserve meeting on June 11, represents one of the biggest…

Read more 12
Tencent Shares Jump 3.3% After $4.66 Billion Bond Sale Attracts Strong Demand
📅 2 hours ago

Tencent Shares Jump 3.3% After $4.66 Billion Bond Sale Attracts Strong Demand

Tencent Shares gained strong attention in global markets after a fresh surge in investor confidence. Shares of Tencent Holdings reportedly rose around 3.3% following news of a successful $4.66 billion bond sale. The move reflects growing confidence in China’s major tech industry and highlights Tencent’s strong financial position. The bond offering attracted strong demand from…

Read more 12
Steadfast Shares Soar 36% After A$7.7 Billion Takeover Bid From Amwins, Dragoneer
📅 2 hours ago

Steadfast Shares Soar 36% After A$7.7 Billion Takeover Bid From Amwins, Dragoneer

Shares of Steadfast surged 36% after the insurance broking giant received a takeover proposal valued at approximately A$7.7 billion from a consortium led by Amwins and Dragoneer. The announcement immediately attracted investor attention and became one of the biggest stories in the Australian stock market. The proposed deal represents a significant premium over Steadfast’s previous…

Read more 12
Concord Biotech Shares Jump 5.9% After US FDA Approves Tofacitinib Arthritis Drug
📅 2 hours ago

Concord Biotech Shares Jump 5.9% After US FDA Approves Tofacitinib Arthritis Drug

Shares of Concord Biotech saw strong buying interest after a key global development. The stock rose around 5.9% in recent trading sessions after news of a US FDA approval related to its Tofacitinib-based arthritis drug. The trigger is important. The US Food and Drug Administration (FDA) approval opens doors to the world’s largest pharmaceutical market….

Read more 12

AMBI News FAQ